respiratori
syncyti
viru
rsv
signific
caus
lower
respiratori
tract
infect
infant
usual
requir
hospit
occurr
death
extrem
case
past
decad
mani
studi
clearli
demonstr
rsv
seriou
pathogen
certain
adult
popul
includ
longterm
care
facil
immunocompromis
host
although
rsv
infect
adult
often
mild
effect
rsv
infect
substanti
healthi
adult
hospit
patient
rsv
infect
caus
signific
morbid
hospit
patient
mortal
rate
recent
studi
show
hospit
communityacquir
pneumonia
relat
viral
pathogen
influenza
rsv
compris
among
viral
pathogen
respect
retrospect
cohort
studi
show
rsv
infect
combin
bacteri
coinfect
associ
increas
risk
mortal
rsv
infect
may
contribut
case
chronic
obstruct
pulmonari
diseas
copd
exacerb
asthma
admiss
adult
viru
infect
includ
rsv
may
explain
season
mortal
elderli
influenza
attribut
mortal
time
higher
rsv
elderli
populationbas
studi
howev
attribut
mortal
influenza
less
time
compar
rsv
attribut
hospit
due
rsv
almost
twothird
influenza
rsv
increasingli
common
caus
ill
high
morbid
adult
better
understand
complic
outcom
adult
hospit
rsv
compar
influenza
infect
would
use
identifi
highrisk
adult
furthermor
oseltamivir
commonli
prescrib
influenza
infect
patient
sinc
howev
efficaci
oseltamivir
treatment
contradictori
investig
allcaus
mortal
rate
hospit
admit
patient
laboratori
confirm
rsv
compar
influenza
also
investig
effect
oseltamivir
mortal
patient
influenza
infect
retrospect
cohort
studi
hospit
adult
rsv
infect
conduct
patient
age
year
admit
januari
decemb
suspect
respiratori
viral
infect
n
studi
physician
suspect
respiratori
viral
ill
viru
multiplex
pcr
perform
exclud
subject
identifi
viral
infect
patient
viral
infect
influenza
ab
rsv
infect
fig
rsv
patient
n
compar
patient
diagnos
season
influenza
n
period
one
patient
mix
infect
influenza
rsv
among
rsvinfect
patient
one
patient
mix
infect
bocaviru
among
influenzainfect
patient
patient
mix
infect
bocaviru
patient
coronaviru
patient
mix
infect
includ
studi
except
one
patient
mix
infect
influenza
rsv
current
studi
approv
institut
review
board
dongsan
hospit
keimyung
univers
school
medicin
need
written
inform
consent
waiv
studi
conduct
complianc
declar
helsinki
upper
respiratori
infect
defin
presenc
one
follow
respiratori
symptom
cough
sputum
product
rhinorrhea
sore
throat
dyspnea
pneumonia
defin
presenc
new
progress
infiltr
found
use
chest
radiographi
addit
two
follow
fever
sputum
product
rhinorrhea
sore
throat
dyspnea
diagnosi
pneumonia
attend
physician
outcom
design
allcaus
mortal
day
hospit
admiss
studi
period
nasopharyng
specimen
obtain
use
flock
swab
store
transport
use
univers
transport
medium
copan
brescia
itali
nasopharyng
specimen
submit
respiratori
viru
detect
nucleic
acid
extract
specimen
use
viral
viral
dnarna
extract
kit
intron
biotechnolog
seongnam
korea
cdna
synthes
extract
rna
sampl
cdna
synthesi
premix
seegen
seoul
korea
geneamp
pcr
system
thermal
cycler
appli
biomateri
foster
citi
ca
usa
respiratori
viru
rv
test
perform
detect
follow
virus
adenoviru
influenza
virus
b
rsv
rsv
b
parainfluenza
virus
rhinoviru
abc
metapneumoviru
enteroviru
coronaviru
coronaviru
coronaviru
bocaviru
test
intern
control
ad
specimen
check
entir
process
nucleic
acid
extract
pcr
accord
manufactur
instruct
anyplex
ii
detect
kit
seegen
seoul
korea
use
detect
type
rna
virus
two
type
dna
virus
accord
manufactur
instruct
briefli
assay
conduct
final
volum
contain
cdna
rv
primer
solut
master
mix
realtim
pcr
detect
system
biorad
laboratori
inc
hercul
ca
usa
studi
perform
keimyung
univers
dongsan
hospit
tertiari
care
teach
hospit
daegu
republ
korea
patient
episod
acut
respiratori
infect
emerg
depart
outpati
clinic
within
day
admiss
underw
multiplex
rtpcr
test
adult
patient
year
age
underw
multiplex
rtpcr
test
januari
decemb
identifi
electron
medic
record
collect
clinic
data
use
electron
medic
record
gener
characterist
comorbid
present
symptom
lower
respiratori
complic
requir
supplement
oxygen
therapi
andor
ventilatori
support
hospit
durat
allcaus
mortal
chest
radiographi
perform
patient
admit
hospit
radiograph
interpret
perform
rsv
influenza
case
radiologist
addit
laboratori
investig
perform
base
result
routin
blood
test
sputum
sampl
collect
bacteri
cultur
prepar
admiss
hospit
blood
cultur
also
perform
indic
pneumonia
sever
index
psi
consist
four
part
demograph
includ
age
sex
comorbid
physic
examin
laboratori
find
psi
score
collect
everi
admit
patient
contact
patient
famili
phone
identifi
surviv
clinic
inform
patient
follow
regularli
baselin
characterist
includ
age
sex
resid
longterm
care
facil
comorbid
present
symptom
complic
date
admiss
case
control
patient
summar
use
descript
statist
proport
mean
standard
deviat
sd
chisquar
test
appli
comparison
categor
variabl
twotail
ttest
comparison
continu
variabl
p
valu
consid
statist
signific
fiftytwo
patient
miss
data
bodi
temperatur
due
lack
measur
outpati
clinic
imput
miss
valu
bodi
temperatur
rsv
group
influenza
group
use
sequenti
regress
approach
assum
bodi
temperatur
miss
random
condit
covari
includ
analysi
univari
multivari
cox
regress
model
use
evalu
risk
death
rsv
infect
compar
season
influenza
pneumonia
sever
index
psi
score
resid
longterm
care
facil
exclud
final
model
due
multicollinear
age
multicollinear
adjust
variabl
check
varianc
inflat
factor
vif
toler
statist
largest
vif
psi
score
averag
vif
smallest
toler
psi
score
howev
detail
collinear
diagnost
indic
collinear
age
psi
score
age
resid
longterm
care
facil
enter
simultan
model
hazard
ratio
age
chang
polar
analyz
surviv
curv
case
control
subject
method
compar
use
logrank
test
assess
assumpt
proport
hazard
graphic
goodnessoffit
gof
approach
consid
tie
use
cox
proport
hazard
breslow
method
adjust
made
sex
age
chronic
obstruct
pulmonari
diseas
bodi
temperatur
pneumonia
hypoxemia
bacteri
superinfect
select
covari
model
build
base
clinic
relev
avail
candid
variabl
adjust
sex
age
resid
longterm
care
facil
copd
high
bodi
temperatur
pneumonia
bacteri
superinfect
hypoxemia
psi
score
statist
analys
perform
use
ibm
spss
spss
version
microsoft
window
ibm
armonk
ny
rsv
season
peak
occur
januari
decemb
januari
fig
influenza
season
defin
period
januari
april
determin
base
weekli
surveil
report
influenza
respiratori
virus
prepar
korea
center
diseas
control
prevent
rsv
infect
diagnos
adult
patient
b
influenza
infect
adult
patient
b
studi
period
percentag
test
posit
rate
period
rsv
infect
influenza
respect
among
patient
test
respiratori
virus
multiplex
pcr
averag
age
rsvinfect
patient
older
influenza
patient
year
respect
tabl
rsv
patient
like
resid
longterm
care
facil
copd
pneumonia
respiratori
bacteri
superinfect
hypoxemia
frequent
bodi
temperatur
less
common
rsv
patient
influenza
patient
tabl
oseltamivir
prescrib
influenza
patient
mechan
ventil
use
patient
rsv
infect
patient
influenza
mean
psi
score
point
higher
rsv
infect
influenza
allcaus
mortal
rate
higher
rsv
patient
influenza
patient
respect
fig
adjust
potenti
confound
comorbid
hazard
ratio
hr
confid
interv
ci
allcaus
mortal
significantli
higher
rsv
influenza
tabl
eighti
percent
influenza
viru
infect
patient
treat
oseltamivir
n
patient
prescrib
oseltamivir
n
less
like
treat
oseltamivir
diabet
otherwis
similar
group
tabl
oseltamivirtr
patient
signific
differ
mortal
patient
treat
oseltamivir
allcaus
mortal
rate
respect
p
fig
studi
show
allcaus
mortal
within
day
hospit
admiss
higher
patient
rsv
infect
influenza
adjust
hazard
ratio
rsv
vs
influenza
ci
howev
oseltamivir
signific
effect
mortal
patient
influenza
previou
epidemiolog
studi
retrospect
cohort
suggest
mortal
rate
relat
rsv
infect
elderli
estim
vari
mortal
rate
relat
rsv
infect
might
explain
high
viral
load
sever
infect
studi
high
psi
score
rsv
infect
might
repres
sever
infect
may
partli
explain
higher
mortal
rsv
infect
current
studi
previous
report
rsv
infect
signific
caus
death
infant
less
month
age
seriou
problem
rsv
underestim
elderli
individu
epidemiolog
studi
reveal
rsv
infect
like
influenza
infect
also
signific
caus
death
morbid
elderli
individu
howev
risk
mortal
rsv
infect
presenc
comorbid
confound
explor
well
present
studi
show
rsv
infect
independ
risk
factor
mortal
adjust
variabl
although
rsv
data
base
antigen
detect
viral
isol
method
antigen
detect
test
use
surveil
report
sinc
addit
rsv
realtim
pcr
detect
influenza
virus
implement
sinc
realtim
pcr
sensit
antigen
detect
viru
isol
may
differ
descript
epidemiolog
pre
post
pcr
time
period
thu
detect
method
may
influenc
viru
epidemiolog
therefor
would
reason
direct
comparison
previou
epidemiolog
studi
present
studi
oseltamivir
therapi
show
effect
reduc
mortal
influenza
infect
howev
still
controversi
effect
oseltamivir
outcom
influenzainfect
patient
present
studi
oseltamivir
prescrib
almost
influenza
infect
case
although
differ
mortal
rate
fail
reach
statist
signific
trend
toward
influenzainfect
patient
treat
oseltamivir
lower
mortal
rate
influenzainfect
patient
treat
oseltamivir
suspect
oseltamivir
may
partli
contribut
differ
mortal
rate
rsv
influenza
infect
case
present
studi
studi
show
adult
patient
rsv
infect
also
caus
pneumonia
result
respiratori
failur
higher
proport
season
influenza
rsv
signific
caus
lower
respiratori
tract
infect
infant
young
children
known
signific
caus
sever
acut
respiratori
infect
elderli
peopl
studi
pneumonia
diagnos
patient
similar
result
observ
nurs
home
elderli
outbreak
rsv
infect
present
studi
patient
rsv
infect
exhibit
lower
bodi
temperatur
frequent
patient
influenza
walsh
et
al
also
report
rsv
infect
commonli
associ
lower
temperatur
influenza
greater
proport
rsv
patient
develop
pneumonia
influenza
patient
similar
result
previous
observ
studi
falsey
et
al
dowel
et
al
psi
develop
clinic
predict
tool
guid
doctor
decid
inpati
outpati
treatment
pneumonia
patient
viral
pneumonia
may
detect
use
simpl
chest
radiographi
howev
ground
glass
opac
identifi
use
chest
comput
tomographi
furthermor
rsv
influenza
infect
may
signific
impact
vital
sign
well
laboratori
find
present
studi
psi
score
significantli
higher
rsv
infect
case
influenza
case
point
specul
rsv
infect
may
result
seriou
inflammatori
respons
influenza
infect
although
rsv
infect
account
adult
respiratori
viral
infect
present
studi
rsv
infect
regard
insignific
patient
suspect
rsv
infect
prompt
test
respiratori
viru
first
step
toward
confirm
diagnosi
treat
patient
addit
perform
test
result
made
avail
quickli
identif
viru
well
patient
high
risk
death
would
help
prescrib
antivir
therapi
appropri
recent
advanc
develop
antivir
therapi
rsv
promis
ensur
option
treat
rsv
infect
near
futur
effect
vaccin
rsv
becom
avail
would
prudent
target
high
preval
group
nurs
home
resid
studi
sever
limit
first
absenc
rsv
influenza
nasopharynx
exclud
presenc
rsv
influenza
lower
respiratori
tract
thu
result
may
underestim
rsv
infect
influenza
lower
respiratori
tract
infect
howev
unlik
affect
hr
estim
second
take
consider
vaccin
influenza
may
reduc
impact
influenza
ill
third
data
retrospect
collect
miss
data
inadequ
document
includ
time
start
medic
may
result
bias
studi
analysi
fourth
need
valid
result
extend
hospit
limit
sourc
patient
studi
show
although
rsv
detect
less
frequent
hospit
adult
patient
associ
significantli
higher
risk
allcaus
mortal
season
influenza
